Ardent Health Partners’ (ARDT) Outperform Rating Reiterated at Royal Bank of Canada

Ardent Health Partners (NYSE:ARDT)‘s stock had its “outperform” rating reissued by Royal Bank of Canada in a research note issued on Thursday,Benzinga reports. They currently have a $23.00 price target on the stock. Royal Bank of Canada’s price objective suggests a potential upside of 38.64% from the company’s previous close.

A number of other research analysts have also recently commented on ARDT. Loop Capital assumed coverage on Ardent Health Partners in a research report on Monday, August 12th. They issued a “buy” rating and a $18.00 price target on the stock. Leerink Partnrs upgraded Ardent Health Partners to a “strong-buy” rating in a research report on Monday, August 12th. JPMorgan Chase & Co. assumed coverage on Ardent Health Partners in a research report on Monday, August 12th. They issued a “neutral” rating and a $18.00 price target on the stock. Mizuho assumed coverage on Ardent Health Partners in a research report on Monday, August 12th. They issued an “outperform” rating and a $20.00 price target on the stock. Finally, KeyCorp assumed coverage on Ardent Health Partners in a research report on Friday, October 11th. They issued an “overweight” rating and a $24.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $21.82.

Ardent Health Partners Trading Down 6.9 %

ARDT stock opened at $16.59 on Thursday. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The stock’s fifty day moving average price is $18.18. Ardent Health Partners has a fifty-two week low of $14.57 and a fifty-two week high of $20.72.

Ardent Health Partners (NYSE:ARDT) last posted its quarterly earnings data on Wednesday, August 14th. The company reported $0.35 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.05. The firm had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.46 billion. Equities analysts predict that Ardent Health Partners will post 1.25 EPS for the current fiscal year.

Institutional Trading of Ardent Health Partners

Several large investors have recently bought and sold shares of the business. Wellington Management Group LLP acquired a new stake in shares of Ardent Health Partners during the third quarter valued at about $28,724,000. Point72 Asset Management L.P. acquired a new stake in shares of Ardent Health Partners during the third quarter valued at about $27,428,000. Goldentree Asset Management LP acquired a new stake in shares of Ardent Health Partners during the third quarter valued at about $22,897,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of Ardent Health Partners during the third quarter valued at about $13,119,000. Finally, Soros Fund Management LLC acquired a new stake in shares of Ardent Health Partners during the third quarter valued at about $4,595,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.